Your browser doesn't support javascript.
loading
Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial.
Fam, Maged D; Hanley, Daniel; Stadnik, Agnieszka; Zeineddine, Hussein A; Girard, Romuald; Jesselson, Michael; Cao, Ying; Money, Lynn; McBee, Nichol; Bistran-Hall, Amanda J; Mould, W Andrew; Lane, Karen; Camarata, Paul J; Zuccarello, Mario; Awad, Issam A.
Afiliação
  • Fam MD; Clinical Trials Unit, Neurovascular Surgery Program, Section of Neurosurgery, University of Chicago Medicine, Chicago, Illinois.
  • Hanley D; Division of Brain Injury Outcomes, Department of Neurology, Johns Hopkins Medical Institutions.
  • Stadnik A; Clinical Trials Unit, Neurovascular Surgery Program, Section of Neurosurgery, University of Chicago Medicine, Chicago, Illinois.
  • Zeineddine HA; Clinical Trials Unit, Neurovascular Surgery Program, Section of Neurosurgery, University of Chicago Medicine, Chicago, Illinois.
  • Girard R; Clinical Trials Unit, Neurovascular Surgery Program, Section of Neurosurgery, University of Chicago Medicine, Chicago, Illinois.
  • Jesselson M; Clinical Trials Unit, Neurovascular Surgery Program, Section of Neurosurgery, University of Chicago Medicine, Chicago, Illinois.
  • Cao Y; Clinical Trials Unit, Neurovascular Surgery Program, Section of Neurosurgery, University of Chicago Medicine, Chicago, Illinois.
  • Money L; Department of Neurosurgery, University of Cincinnati, Cincinnati, Ohio.
  • McBee N; Division of Brain Injury Outcomes, Department of Neurology, Johns Hopkins Medical Institutions.
  • Bistran-Hall AJ; Division of Brain Injury Outcomes, Department of Neurology, Johns Hopkins Medical Institutions.
  • Mould WA; Division of Brain Injury Outcomes, Department of Neurology, Johns Hopkins Medical Institutions.
  • Lane K; Division of Brain Injury Outcomes, Department of Neurology, Johns Hopkins Medical Institutions.
  • Camarata PJ; Department of Neurosurgery, University of Kansas School of Medicine, Kansas City, Kansas; Investigators of the MISTIE III Trial.
  • Zuccarello M; Department of Neurosurgery, University of Cincinnati, Cincinnati, Ohio.
  • Awad IA; Clinical Trials Unit, Neurovascular Surgery Program, Section of Neurosurgery, University of Chicago Medicine, Chicago, Illinois.
Neurosurgery ; 81(5): 860-866, 2017 Nov 01.
Article em En | MEDLINE | ID: mdl-28402516
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hemorragia Cerebral / Ativador de Plasminogênio Tecidual / Procedimentos Cirúrgicos Minimamente Invasivos / Fibrinolíticos / Hematoma Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Neurosurgery Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hemorragia Cerebral / Ativador de Plasminogênio Tecidual / Procedimentos Cirúrgicos Minimamente Invasivos / Fibrinolíticos / Hematoma Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Neurosurgery Ano de publicação: 2017 Tipo de documento: Article